Covalent inhibitors of KRAS G12C
US-RE50527-E · Aug 12, 2025 · US
This page is not indexed by search engines while we improve data quality.
Araxes Pharma Llc — Physics
Araxes Pharma Llc holds 17 patents in Physics, with representative filings summarized below.
| Metric | Value |
|---|---|
| Company | Araxes Pharma Llc |
| Technology | Physics |
| Patents in slice | 17 |
| Recent patents in slice | 1 |
| First year | 2016 |
| Last year | 2025 |
Representative patents
Notable publications linking Araxes Pharma Llc to Physics.
Covalent inhibitors of KRas G12C
US-10919850-B2 · Feb 16, 2021 · US
Inhibitors of KRAS G12C mutant proteins
US-10858343-B2 · Dec 8, 2020 · US
Inhibitors of KRAS G12C mutant proteins
US-10858343-B2 · Dec 8, 2020 · US
Covalent inhibitors of kras g12c
US-2019389796-A1 · Dec 26, 2019 · US
Recent filings
Latest patents from Araxes Pharma Llc in Physics.
Covalent inhibitors of KRAS G12C
US-RE50527-E · Aug 12, 2025 · US
Covalent inhibitors of KRas G12C
US-10919850-B2 · Feb 16, 2021 · US
Inhibitors of KRAS G12C mutant proteins
US-10858343-B2 · Dec 8, 2020 · US
Inhibitors of KRAS G12C mutant proteins
US-10858343-B2 · Dec 8, 2020 · US
Covalent inhibitors of kras g12c
US-2019389796-A1 · Dec 26, 2019 · US
Related pages
Navigate to parent entity pages.